BioPharma APAC - Leading Source of Biopharmaceutical Intelligence in Asia Pacific

Bio Reports

Life Sciences CEOs Bet Big on AI and Workforce Growth Despite Economic and Industry Headwinds

Life Sciences CEOs bullish on growth prospects and AI investment despite economic challenges Seventy-nine percent of life sciences CEOs are conf...

November 26, 2024 | Report

Special Report: APAC Healthcare Leaders Prioritize Sustainability Amid Global Challenges

Royal Philips , a global leader in health technology, has released the second set of findings from the Asia Pacific (APAC) Future Health Index (FHI) 2024 r...

November 26, 2024 | Report

Roche's Vabysmo Shows Promising Results in Treating Polypoidal Choroidal Vasculopathy in Asian Patients

Roche shared encouraging 16-week interim data from its ongoing Phase 3b/4 SALWEEN trial, revealing significant advancements in vision improvement and...

November 22, 2024 | News

Merck and Abbisko Report Positive Phase III Results for Pimicotinib in TGCT Across Asia, Europe, and North America

Phase III MANEUVER study met primary endpoint, with an objective response rate at week 25 of 54.0% for pimicotinib versus 3.2% for placebo (p<0.0001) ...

November 21, 2024 | News

Ascletis Completes Enrollment for Phase III Trial of ASC40 in Acne

Phase III trial enrolled a total of 480 patients with moderate to severe acne-Topline results expected in the second quarter 2025 Ascletis Pharma Inc. ann...

November 13, 2024 | News

China’s Gan & Lee’s GZR18 Injection Achieves Up to 17.8% Weight Loss in Phase 2b Trial

Obese or overweight participants receiving bi-weekly doses of 12 mg, 18 mg, 24 mg, 48 mg, and once-weekly dose of 24 mg GZR18 for 30 weeks achieved mean ...

November 12, 2024 | News

Ascletis' ASC47 Shows Promise in Phase I Trial with Once-Monthly Dosing and Superior Fat Reduction in Obesity Treatment

Data from a Phase I single ascending dose (SAD) study in Australia in subjects with elevated low-density lipoprotein cholesterol (LDL-C) showed...

November 08, 2024 | News

Powering Up Cartilage: New Mitochondrial Therapy Offers Fresh Hope for Osteoarthritis Patients

Researchers have discovered a promising new method for potentially treating osteoarthritis (OA), a debilitating joint disease for which there are currently...

November 08, 2024 | News

Minghui Pharmaceutical Announces Promising Phase I Results for MHB039A, a PD-1 x VEGF Bispecific Antibody, in Solid Tumor Treatment in China

Minghui Pharmaceutical, Inc., a late-stage biopharmaceutical company focused on developing transformative medicines in immunology and oncology, today annou...

November 07, 2024 | News

Breast Cancer Drug Shows Promise for Treating Hereditary Hemorrhagic Telangiectasia, a Rare Vascular Disorder

A drug commonly used to treat breast cancer might be able to help people living with hereditary hemorrhagic telangiectasia (HHT) – a rare genetic ble...

November 05, 2024 | News

AllazoHealth’s AI Personalization Boosts Therapy Initiation by 10.4% for Rare Disease Patients

AllazoHealth, a leader in AI-driven solutions for enhancing therapy initiation, adherence, and health outcomes, today announced the release of a compelling...

November 01, 2024 | News

Innovent's Picankibart Shows Promising Results in Phase 2 Trial for Psoriasis Patients Unresponsive to Previous Biologics

Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high-quality me...

October 29, 2024 | News

Corvia Medical’s Atrial Shunt Demonstrates Long-Term Efficacy in Heart Failure Patients: Three-Year Trial Results Published

Corvia Medical, Inc, a company dedicated to transforming the treatment of heart failure, announced impressive three-year results from its REDUCE LAP-HF II ...

October 28, 2024 | News

Lunit AI Cuts Radiologist Workload by 50% While Predicting Cancer Risk Up to Six Years in Advance, New Studies Show

Two new studies show Lunit INSIGHT MMG cuts radiologist workload by 50% in a double reading environment while maintaining or improving screening qua...

October 24, 2024 | News

Stay Connected